Embla Medical hf. (OTCMKTS:OSSFF – Get Free Report) is expected to post its resultson Tuesday, October 20th. Analysts expect the company to announce earnings of $0.0673 per share and revenue of $254.53 million for the quarter.
Embla Medical hf. Stock Performance
Embla Medical hf. stock opened at $4.53 on Friday. The stock has a 50-day moving average price of $4.43 and a 200 day moving average price of $4.25. Embla Medical hf. has a 52 week low of $4.53 and a 52 week high of $4.55.
About Embla Medical hf.
Embla Medical hf. is an Icelandic medical technology company focused on mobility solutions for people with limb loss, limb difference and physical disabilities. The company develops, manufactures and distributes prosthetic and orthotic products designed to support movement, stability and rehabilitation.
Its product portfolio includes prosthetic limbs and components, liners and suspension systems, bionic and mechanical knee and foot solutions, orthotic braces, supports and related patient-care technologies.
Read More
- Five stocks we like better than Embla Medical hf.
- Rocket Lab’s Neutron Delay Leaves Wall Street Bullish But Raises the Stakes for 2027
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
Receive News & Ratings for Embla Medical hf. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Embla Medical hf. and related companies with MarketBeat.com's FREE daily email newsletter.
